c-Met: A Promising Therapeutic Target in Bladder Cancer

被引：13
|
作者：
Feng, Yanfei [1 ]
Yang, Zitong [2 ]
Xu, Xin [2 ,3 ]
机构：
[1] Zhejiang Chinese Med Univ, Affiliated Coll 2, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Urol, 79th Qingchun Rd, Hangzhou 310003, Peoples R China
来源：
CANCER MANAGEMENT AND RESEARCH | 2022年 / 14卷
基金：
中国国家自然科学基金;
关键词：
c; -Met; HGF; noncoding RNA; bladder cancer; review; HEPATOCYTE GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; URINARY-BLADDER; SCATTER FACTOR; PROGNOSTIC INDICATOR; LUNG ADENOCARCINOMA; EXPRESSION; MIGRATION;
D O I：
10.2147/CMAR.S369175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Mesenchymal-epithelial transition factor (c-Met) belongs to the tyrosine kinase receptor family and is overexpressed in various human cancers. Its ligand is hepatocyte growth factor (HGF), and the HGF/c-Met signaling pathway is involved in a wide range of cellular processes, including cell proliferation, migration, and metastasis. Emerging studies have indicated that c-Met expression is strongly associated with bladder cancer (BCa) development and prognosis. Therefore, c-Met is a potential therapeutic target for BCa treatment. Recently, the aberrant expression of noncoding RNAs was found to play a significant role in tumour progression. There is a close connection between c-Met and noncoding RNA. Herein, we summarized the biological function and prognostic value of c-Met in BCa, as well as its potential role as a drug target. The relation of c-Met and ncRNA was also described in the paper.
引用
收藏
页码：2379 / 2388
页数：10
相关论文
共 50 条
  • [11] c-Met Overexpression in Cervical Cancer: A Prognostic Factor and a Potential Molecular Therapeutic Target
    Refaat, T.
    Donnelly, E. D.
    Sachdev, S.
    Parimi, V.
    El Achy, S.
    Dalal, P.
    Farouk, M.
    Berg, K. N.
    Helenowksi, I.
    Gross, J.
    Lurain, J.
    Strauss, J. B.
    Woloschak, G. E.
    Wei, J. J.
    Small, W., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E252 - E252
  • [12] C-Met is a potential therapeutic target for antibody-drug conjugates in breast cancer
    Fu, Yanwen
    Gros, Edwige
    Lee, Alice
    Johnson, Kimberly
    Zhang, Hong
    Yalamanchili, Silpa
    Motamed, Kouros
    Chen, Gary
    Jones, Bryan
    Miao, David
    Kaufmann, Gunnar F.
    CANCER RESEARCH, 2015, 75
  • [13] c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target
    Refaat, Tamer
    Donnelly, Eric D.
    Sachdev, Sean
    Parimi, Vamsi
    El Achy, Samar
    Dalal, Prarthana
    Farouk, Mohamed
    Berg, Natasha
    Helenowski, Irene
    Gross, Jeffrey P.
    Lurain, John
    Strauss, Jonathan B.
    Woloschak, Gayle
    Wei, Jian-Jun
    Small, William, Jr.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (06): : 590 - 597
  • [14] The receptor tyrosine kinase c-MET as a novel therapeutic target in head and neck cancer
    Seiwert, T.
    Janamanchi, V.
    Klein-Szanto, A.
    Jagadeeswaran, R.
    Martin, L.
    Lingen, M.
    Cohen, E.
    Ridge, J.
    Vokes, E.
    Salgia, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02): : S137 - S137
  • [15] Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
    Bouattour, Mohamed
    Raymond, Eric
    Qin, Shukui
    Cheng, Ann-Lii
    Stammberger, Uz
    Locatelli, Giuseppe
    Faivre, Sandrine
    HEPATOLOGY, 2018, 67 (03) : 1132 - 1149
  • [16] Androgen receptor in bladder cancer: A promising therapeutic target
    Tripathi, Abhishek
    Gupta, Shilpa
    ASIAN JOURNAL OF UROLOGY, 2020, 7 (03) : 284 - 290
  • [17] c-met and HGF-α in advanced Cervical cancer FIGO III and IV - a therapeutic Target?
    Horn, L. -C.
    Hommel, N.
    Einenkel, J.
    Hentschel, B.
    ONKOLOGIE, 2010, 33 : 115 - 116
  • [18] MET: a promising anticancer therapeutic target
    Peters, Solange
    Adjei, Alex A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (06) : 314 - 326
  • [19] MET: a promising anticancer therapeutic target
    Solange Peters
    Alex A. Adjei
    Nature Reviews Clinical Oncology, 2012, 9 : 314 - 326
  • [20] c-Met receptor tyrosine kinase: A novel molecular therapeutic target for the treatment of pancreatic cancer
    Jagadeeswaran, Ramasamy
    Ahmed, Salman
    Janamanchi, Varalakshmi
    Surawska, Hanna
    Karikari, Collins
    Maitra, Anirban
    Salgia, Ravi
    CANCER RESEARCH, 2006, 66 (08)
12345